| __timestamp | Geron Corporation | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8901000 | 3788000000 |
| Thursday, January 1, 2015 | 9574000 | 4006000000 |
| Friday, January 1, 2016 | 14695000 | 4261000000 |
| Sunday, January 1, 2017 | 8437000 | 4371000000 |
| Monday, January 1, 2018 | 12723000 | 4853000000 |
| Tuesday, January 1, 2019 | 51272000 | 4675000000 |
| Wednesday, January 1, 2020 | 50052000 | 4572000000 |
| Friday, January 1, 2021 | 783000 | 6601000000 |
| Saturday, January 1, 2022 | 868000 | 5657000000 |
| Sunday, January 1, 2023 | 123740000 | 6498000000 |
| Monday, January 1, 2024 | 28675800000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, Gilead Sciences, Inc. and Geron Corporation stand as intriguing case studies in cost management. From 2014 to 2023, Gilead Sciences consistently reported a cost of revenue that dwarfed Geron's, with figures peaking at approximately $6.6 billion in 2021. This represents a staggering 1,000-fold increase compared to Geron's highest cost of revenue, which reached around $123 million in 2023.
While Gilead's cost of revenue saw a steady climb, reflecting its expansive operations and market reach, Geron's figures remained relatively modest, with significant fluctuations. Notably, Geron's cost of revenue spiked in 2019 and 2023, hinting at strategic shifts or investments. This contrast underscores the diverse strategies employed by biotech firms in managing operational costs, with Gilead's scale offering both opportunities and challenges in cost efficiency.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Gilead Sciences, Inc.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs HUTCHMED (China) Limited
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Mesoblast Limited
Comparing Cost of Revenue Efficiency: Neurocrine Biosciences, Inc. vs Geron Corporation
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Geron Corporation
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Cost of Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Geron Corporation
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored